EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salivary Cortisone as a Potential Alternative to Cortisol in Periodontitis Severity Assessment

Dimitar Dimitrov iD, Antoaneta Mlachkova iD, Velitchka Dosseva-Panova iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27020805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Dimitar Dimitrov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Faculty of Dental Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Cortisone, Saliva, Hydrocortisone, Periodontitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Ministry of Education and Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salivary cortisol is widely used to investigate stress–periodontitis interactions, but its measurement is affected by methodological limitations. Cortisone, the predominant salivary glucocorticoid, may offer analytical advantages, yet its role in periodontitis remains unexplored. This study evaluated salivary cortisone in relation to periodontal disease severity and compared its performance with cortisol. Sixty-seven periodontitis patients were classified as Stage I/II (n = 32) or Stage III/IV (n = 35). A comprehensive periodontal examination was performed, including FMPS, FMBS, PPD, CAL, BoP, and the BL/Age ratio. Unstimulated morning saliva samples were analyzed for cortisone and cortisol using liquid chromatography–tandem mass spectrometry, and for IL-1β and IL-6 using ELISA. Both cortisone and cortisol levels were significantly higher in Stage III/IV periodontitis (p = 0.014). Cortisone correlated strongly with cortisol (ρ = 0.523, p < 0.001) and was positively associated with IL-6 (ρ = 0.322, p = 0.008) and multiple clinical indicators of periodontal disease severity. ROC analysis showed comparable discriminatory performance for cortisone and cortisol (AUC = 0.675), with cortisone demonstrating higher specificity (94%) for Stage III/IV periodontitis. Our findings suggest that salivary cortisone performs similarly to cortisol and warrants further investigation as an alternative salivary glucocorticoid marker in periodontal research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CortisoneSalivaHydrocortisonePeriodontitisHumansFemaleMaleMiddle AgedAdultBiomarkersSeverity of Illness IndexInterleukin-6

Stichwörter der Autor:innen

cortisolglucocorticoidsinflammationperiodontitissalivary cortisonestress

Substanzen

CortisoneHydrocortisoneBiomarkersInterleukin-6

Autor:innen und Institutionen

  • Department of Periodontology, Faculty of Dental Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.

ORCID-Profile: Dimitar Dimitrov, Antoaneta Mlachkova, Velitchka Dosseva-Panova

Förderung

  • Bulgarian Ministry of Education and Science

Zitieren

APA

Dimitrov, D., Mlachkova, A., & Dosseva-Panova, V. (2026). Salivary Cortisone as a Potential Alternative to Cortisol in Periodontitis Severity Assessment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020805

Vancouver

Dimitrov D, Mlachkova A, Dosseva-Panova V. Salivary Cortisone as a Potential Alternative to Cortisol in Periodontitis Severity Assessment. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020805

BibTeX
@article{Dimitrov2026,
  author = {Dimitrov, Dimitar and Mlachkova, Antoaneta and Dosseva-Panova, Velitchka},
  title = {Salivary Cortisone as a Potential Alternative to Cortisol in Periodontitis Severity Assessment},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27020805}
}
Kostenlos starten →